Amicus Therapeutics is a leading global rare-disease focused biotechnology company with a clear and compelling mission: to develop and deliver transformative medicines for people living with rare diseases.
We believe that breakthroughs are possible. That is why we push ideas as far and as fast as possible – in our science, in our work with patients, in everything we do – because every moment matters when you are living with a rare disease.